A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
Status:
COMPLETED
Trial end date:
2025-05-02
Target enrollment:
Participant gender:
Summary
This is a Phase II, multi-centre, randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of AZD0780 Dose 1 versus placebo on systolic blood pressure (SBP) at Week 4, as measured by 24-hour ambulatory blood pressure monitoring (ABPM) in participants with ASCVD or risk equivalents and LDL-C 70 mg/dL, on stable medication.